Ratings by Cantor Fitzgerald (Elemer Piros)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | Arrowhead Pharma | ARWR | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/19/2025 | Arrowhead Pharma | ARWR | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/13/2025 | Arrowhead Pharma | ARWR | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2023 | Arrowhead Pharma | ARWR | Maintain | Overweight (N/A) |
|
Details | ||
| 11/24/2020 | Arrowhead Pharma | ARWR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/17/2020 | Unity Biotechnology Inc | UBX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2020 | GW Pharma | GWPH | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2020 | Arrowhead Research | ARWR | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2020 | Marinus Pharmaceuticals | MRNS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/15/2020 | Arrowhead Research | ARWR | Upgrade | Buy (Neutral) |
36.77 (74.52) |
102.67% | Details | |
| 2/6/2020 | Arrowhead Research | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 12/12/2019 | Unity Biotechnology Inc | UBX | New Coverage | Overweight (N/A) |
7.72 (0.20) |
-97.41% | Details | |
| 12/5/2019 | Aurinia Pharmaceuticals | AUPH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2019 | GW Pharma | GWPH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/18/2019 | Marinus Pharmaceuticals | MRNS | New Coverage | Overweight (N/A) |
1.33 (0.55) |
-58.65% | Details | |
| 10/8/2019 | Global Blood Therapeutics | GBT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/23/2019 | PolarityTE | PTE | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2019 | Tocagen Inc. | TOCA | Downgrade | Neutral (Overweight) |
4.18 (1.26) |
-69.86% | Details | |
| 9/6/2019 | Durect Corp | DRRX | New Coverage | Overweight (N/A) |
1.66 (1.94) |
16.87% | Details | |
| 8/20/2019 | PolarityTE | PTE | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2019 | Abeona Therapeutics | ABEO | Downgrade | Neutral (Overweight) |
2.29 (5.53) |
141.48% | Details | |
| 7/11/2019 | Dynavax Technologies | DVAX | Upgrade | Overweight (Neutral) |
3.79 (15.50) |
308.97% | Details | |
| 7/8/2019 | uniQure BV | QURE | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/28/2019 | Arrowhead Research | ARWR | Downgrade | Neutral (Overweight) |
27.70 (74.52) |
169.03% | Details | |
| 6/25/2019 | Aldeyra Therapeutics | ALDX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/24/2019 | Krystal Biotech | KRYS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/21/2019 | Mustang Bio | MBIO | New Coverage | Overweight (N/A) |
3.62 (2.57) |
-29.01% | Details | |
| 6/14/2019 | bluebird bio | BLUE | Maintain | Neutral (N/A) |
|
Details | ||
| 6/14/2019 | Global Blood Therapeutics | GBT | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2019 | Aerie Pharma | AERI | Maintain | Overweight (N/A) |
|
Details | ||
| 6/5/2019 | Amicus Therapeutics | FOLD | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/7/2019 | GW Pharma | GWPH | Maintain | Overweight (N/A) |
|
Details | ||
| 4/26/2019 | Tocagen Inc. | TOCA | New Coverage | Overweight (N/A) |
8.52 (4.18) |
-50.94% | Details | |
| 3/26/2019 | Aldeyra Therapeutics | ALDX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/25/2019 | Proteostasis Therapeutics | PTI | Maintain | Overweight (N/A) |
|
Details | ||
| 3/20/2019 | Aurinia Pharmaceuticals | AUPH | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2019 | Abeona Therapeutics | ABEO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2019 | Amicus Therapeutics | FOLD | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2019 | PolarityTE | PTE | Maintain | Overweight (N/A) |
|
Details | ||
| 3/11/2019 | Spring Bank Pharmaceuticals | SBPH | Maintain | Overweight (N/A) |
|
Details | ||
| 3/11/2019 | PolarityTE | PTE | Maintain | Overweight (N/A) |
|
Details | ||
| 3/7/2019 | uniQure BV | QURE | Maintain | Overweight (N/A) |
|
Details | ||
| 3/7/2019 | Unity Biotechnology Inc | UBX | New Coverage | Overweight (N/A) |
10.22 (7.72) |
-24.46% | Details | |
| 3/6/2019 | Marinus Pharmaceuticals | MRNS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/4/2019 | Nightstar Therapeutics | NITE | Downgrade | Neutral (Overweight) |
14.82 (37.45) |
152.7% | Details | |
| 2/27/2019 | Dynavax Technologies | DVAX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2019 | Strongbridge Biopharma | SBBP | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2019 | uniQure BV | QURE | Maintain | Overweight (N/A) |
|
Details | ||
| 2/19/2019 | Galmed Pharmaceuticals | GLMD | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2019 | Amicus Therapeutics | FOLD | New Coverage | Overweight (N/A) |
11.21 (8.94) |
-20.25% | Details | |
| 1/10/2019 | Corbus Pharmaceuticals | CRBP | Maintain | Overweight (N/A) |
|
Details | ||
| 12/10/2018 | Marinus Pharmaceuticals | MRNS | Maintain | Overweight (N/A) |
|
Details | ||
| 12/3/2018 | Ocular Therapeutix | OCUL | Maintain | Overweight (N/A) |
|
Details | ||
| 12/3/2018 | GW Pharma | GWPH | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/3/2018 | Global Blood Therapeutics | GBT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/27/2018 | Proteostasis Therapeutics | PTI | Maintain | Overweight (N/A) |
|
Details | ||
| 11/15/2018 | uniQure BV | QURE | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2018 | Proteostasis Therapeutics | PTI | New Coverage | Overweight (N/A) |
6.93 (1.11) |
-83.98% | Details | |
| 11/2/2018 | bluebird bio | BLUE | Upgrade | Neutral (Underweight) |
130.15 (4.97) |
-96.18% | Details | |
| 10/22/2018 | Dynavax Technologies | DVAX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/15/2018 | Krystal Biotech | KRYS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2018 | Nightstar Therapeutics | NITE | New Coverage | Overweight (N/A) |
15.04 (14.82) |
-1.46% | Details | |
| 10/4/2018 | Arrowhead Research | ARWR | Maintain | Overweight (N/A) |
|
Details | ||
| 9/27/2018 | GW Pharma | GWPH | Maintain | Overweight (N/A) |
|
Details | ||
| 9/26/2018 | PolarityTE | PTE | Maintain | Overweight (N/A) |
|
Details | ||
| 9/26/2018 | Aldeyra Therapeutics | ALDX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/13/2018 | Corbus Pharmaceuticals | CRBP | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2018 | PolarityTE | COOL | Maintain | Overweight (N/A) |
|
Details | ||
| 9/10/2018 | Krystal Biotech | KRYS | New Coverage | Overweight (N/A) |
18.85 (317.97) |
1586.84% | Details |
